Turkish Cargo carries the first batch of the Covid-19 vaccines procured from China’s Sinovac to Turkey. Loaded inside 17 containers equipped with dedicated cooling systems, Covid-19 vaccines were delivered to the officials of Turkey’s Ministry of Health after being successfully transported from Beijing (PEK) to Ankara (ESB) via a dedicated flight.
In order to take on the key mission of transporting medical equipment and pharmaceutical shipments related to the Covid-19 pandemic, Turkish Cargo notes it has increased its capacity by 30 per cent and enhanced its cold chain shipment capacity to 25,000 tonnes per month.
Holding the IATA CEIV (Center of Excellence for Independent Validators) pharma certificate, Turkish Cargo tapped its cold chain specialty product ‘TK Pharma’ which is designed for carrying pharmaceuticals such as medicine and vaccines at global standards.
Saying it maintains a continuous dialog with the pharmaceutical manufacturers, forwarders, airports, ground handling companies, and national authorities, the carrier highlights it is capable of satisfying a wide range of requirements of the pharmaceutical manufacturers by making use of dedicated cool containers and means such as dry ice for the shipments at the ultra-frozen (-70 °C) range of the spectrum.
Turkish Cargo has created a global pharmaceutical corridor between more than 400 destinations by transporting pharmaceuticals to the key and certificated destinations such as Mumbai, Brussels, Istanbul, Singapore, Dubai, Basel, London, and Amsterdam. In total Turkish Cargo reaches more than 300 destinations, 96 of which are direct cargo destinations, alongside an expansive passenger network that provides substantial belly capacity.